Subscribe
Search
Close this search box.
Subscribe
Search
Close this search box.

Immunology

Biomedical/pharma, Healthcare technology, Immunology, Neurology, Personal/public health

Confo-dently into the future!

Confo Therapeutics is a rising star in Belgium, featured on several local and international lists of up-and-coming biotechs. The company, launched in 2015 as a spin-off of the Vrije Universiteit Brussel (VUB) and VIB, is now taking the big step from the preclinical to the clinical stage with a GPCR drug for neuropathic pain.

EsoBiotec ready to transform cell therapy cancer treatments

Moderna: from secretive platform company to vaccine superstar

Malaria vaccine candidate shows promise for African children

Record-breaking pollen levels linked to increased risk of COVID-19

Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center

One year of COVID-19: a look back at 2020 and where we are now

Decades-old discoveries cause paradigm shifts in modern medicine

Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

Vascular dysfunction meets immune suppression

Montis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer

Countering COVID-19 with llama antibodies

A novel approach to neurology could bring relief to people in pain

Biodol Therapeutics receives EUR 4.5 million to progress its novel pain medication in a Series A led by V-Bio Ventures

Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases